A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia
John Schindler, Srikanth Gajavelli, Farhad Ravandi, Yumin Shen, Samir Parekh, Ira Braunchweig, Stefan Barta, Victor Ghetie, Ellen Vitetta, Amit Verma
Research output: Contribution to journal › Article › peer-review
82Scopus
citations
Fingerprint
Dive into the research topics of 'A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia'. Together they form a unique fingerprint.